Alternatives to Lightcast

Lightcast is a Biotechnology tool: AI-powered antibody discovery platform. Here are the 52 closest alternatives, compared on pricing, features and what real users say.

Lightcast profile More Biotechnology alternatives

The 20 closest Biotechnology companies to Lightcast

Antiverse
Not rated
AI-powered antibody discovery platform.
Visit site
Absci
3.0 out of 5 (1)
AI-powered drug discovery and development platform for biologics.
Visit site
AbCellera
Not rated
AI-powered platform for antibody discovery and development to create new medicines.
Visit site
Converge Bio
Not rated
Computational platform using LLMs trained on biological and chemical data for drug discovery.
Visit site
Moderna
2.5 out of 5 (2)
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Visit site
BioNTech
Not rated
Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
Visit site
Epicrispr Biotechnologies
Not rated
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Visit site
Adcendo
Not rated
Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
Visit site
LifeMine Therapeutics Inc.
Not rated
Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
Visit site
Infinimmune
Not rated
Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
Visit site
CellCentric
Not rated
A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
Visit site
Sinopia Biosciences
Not rated
Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.
Visit site
Latus Bio
Not rated
Engineering scalable gene therapies for broader patient populations.
Visit site
mbiomics
Not rated
Advancing scalable microbiome-based therapeutics for severe and chronic diseases.
Visit site
Immitra Bio
Not rated
Scalable, one-time curative in-vivo gene editing therapies.
Visit site
ImmunityBio
Not rated
A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.
Visit site
Houdini Bio
Not rated
Engineering-driven DNA design platform to overcome biological barriers in genetic medicines.
Visit site
Telum Therapeutics
Not rated
Biotechnology company developing novel protein-based antimicrobial therapeutics.
Visit site
Laverock Therapeutics
Not rated
Developing disease-responsive advanced therapies through programmable gene control technology.
Visit site
CRISPR Therapeutics
Not rated
Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
Visit site

Company	Rating	Visit
AntiverseAI-powered antibody discovery platform.	Not rated	Visit site
AbsciAI-powered drug discovery and development platform for biologics.	3.0 out of 5 (1)	Visit site
AbCelleraAI-powered platform for antibody discovery and development to create new medicines.	Not rated	Visit site
Converge BioComputational platform using LLMs trained on biological and chemical data for drug discovery.	Not rated	Visit site
ModernaModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.	2.5 out of 5 (2)	Visit site
BioNTechGlobal biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.	Not rated	Visit site
Epicrispr BiotechnologiesEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).	Not rated	Visit site
AdcendoDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.	Not rated	Visit site
LifeMine Therapeutics Inc.Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.	Not rated	Visit site
InfinimmuneDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.	Not rated	Visit site
CellCentricA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.	Not rated	Visit site
Sinopia BiosciencesBiotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.	Not rated	Visit site
Latus BioEngineering scalable gene therapies for broader patient populations.	Not rated	Visit site
mbiomicsAdvancing scalable microbiome-based therapeutics for severe and chronic diseases.	Not rated	Visit site
Immitra BioScalable, one-time curative in-vivo gene editing therapies.	Not rated	Visit site
ImmunityBioA commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.	Not rated	Visit site
Houdini BioEngineering-driven DNA design platform to overcome biological barriers in genetic medicines.	Not rated	Visit site
Telum TherapeuticsBiotechnology company developing novel protein-based antimicrobial therapeutics.	Not rated	Visit site
Laverock TherapeuticsDeveloping disease-responsive advanced therapies through programmable gene control technology.	Not rated	Visit site
CRISPR TherapeuticsBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.	Not rated	Visit site

Showing the next 20 closest matches. See the rest on the Lightcast profile.

Sponsored rows are paid and labelled. Advertise on this page